Obesity is a disorder associated with metabolic dysfunction and changes in cardiovascular
risk markers; the use of oral contraceptives (OCs) may exert a further negative effect on
these alterations in patients with PCOS.
To assess the effects on arterial function and structure and hemostatic parameters using an
levonorgestrel intrauterine device (IUS-LNG) in women with obesity
A randomized controlled clinical trial.